Failure of acyclovir to enhance the antiviral effect of α lymphoblastoid interferon on HBe-seroconversion in chronic hepatitis B
✍ Scribed by Berk, Lucas; Schalm, Solko W.; de Man, Robert A.; Heytink, Rudolf A.; Berthelot, Pierre; Brechot, Christian; Boboc, Bernard; Degos, Françoise; Marcellin, Patrick; Benhamou, Jean-Pierre
- Book ID
- 123205959
- Publisher
- Elsevier Science
- Year
- 1992
- Tongue
- English
- Weight
- 632 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
In a randomized controlled trial of recombinant a-2a interferon for chronic hepatitis B, interferon antibodies developed in 21 (39%) of 54 Chinese adults who received IFN. No correlation was observed between sex, age, pretreatment serum ALT level or liver histological findings and the development of
Hepatitis B virus DNA clones were propagated from sera of six patients with chronic hepatitis B who seroconverted from HBeAg to antibody to HBeAg either spontaneously or after administration of Q- interferon. Defects in the precore region blocking synthesis and secretion of HBeAg were detected in al